Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
States
/
California

Product Recalls in California

All product recalls affecting California.

Includes nationwide recalls (tagged “Nationwide”) and recalls with California in the distribution area.

Get alerts for California

Showing 3361–3380 of 34515 recalls

Levetiracetam Injection (Dr. Reddy's) – Labeling Error (2025)

LABELING: LABEL MIX-UP: The infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL.

Class IHigh

FDAMar 13, 2025Nationwide• Dr. Reddy's Laboratories, Inc.

Propafenone Extended-Release Capsules (Glenmark) – CGMP Deviations (2025)

CGMP Deviations

Stay Informed

Product Recalls in California

Levetiracetam Injection (Dr. Reddy's) – Labeling Error (2025)

Propafenone Extended-Release Capsules (Glenmark) – CGMP Deviations (2025)

Pravastatin Sodium Tablets (Glenmark) – CGMP Deviations (2025)

Fluphenazine Tablets (Glenmark) – CGMP Deviations (2025)

Fenofibrate Capsules (Glenmark) – CGMP Deviations (2025)

Cetirizine Hydrochloride Tablets 10mg (Glenmark) – CGMP Issues (2025)

Rufinamide Tablets 200mg (Glenmark) – CGMP Issues (2025)

Lacosamide Tablets 150mg (Glenmark) – CGMP Issues (2025)

Lacosamide Tablets 100mg (Glenmark) – CGMP Issues (2025)

Carvedilol Tablets 12.5mg (Glenmark) – CGMP Issues (2025)

Propafenone Extended-Release 225mg (Glenmark) – CGMP Issues (2025)

Lacosamide Tablets 200mg (Glenmark) – CGMP Issues (2025)

Clindamycin Hydrochloride Capsules 300mg (Glenmark) – CGMP Issues (2025)

Lacosamide Tablets 50mg (Glenmark) – CGMP Issues (2025)

Propafenone Extended-Release 225mg (Glenmark) – CGMP Issues (2025)

Voriconazole Tablets 200mg (Glenmark) – CGMP Deviations (2025)

Fluphenazine Hydrochloride Tablets 2.5mg (Glenmark) – CGMP Deviations (2025)

Propafenone Extended-Release 325mg (Glenmark) – CGMP Issues (2025)

Colesvelam Tablets 625mg (Glenmark) – CGMP Issues (2025)

Metformin Extended-Release Tablets (Glenmark) – CGMP Deviations (2025)

Other States